Tetra Bio-Pharma (OTC: TBPMF) Signs Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
This Definitive Agreement is expected to generate an excess of $47,5M CAD in revenue for Tetra OTTAWA, ON / May 5, 2021 /Tetra Bio-Pharma Inc. (“Tetra” or the “Company”)(TSX:TBP)(OTCQB:TBPMF)(FSE:JAM1), a leader in cannabinoid-derived drug discovery and development […]
